To evaluate the pathophysiological function of specific molecules in the renal glomerulus, selective, sustained, and modifiable expression of such molecules will be required. Towards achieving this end, we devised a gene transfer system using the glomerular mesangial cell as a vector for gene delivery. A reporter gene which encodes bacterial j3-galactosidase was introduced into cultured rat mesangial cells, and the stable transfectants were transferred into the rat kidney via the renal artery, leading to selective entrapment within the glomeruli. In the normal kidney, the reporter cells populated into 57+13% of glomeruli site specifically, and the expression of f8-galactosidase was sustained for 4 wk and declined thereafter. Within the glomerulus, some of the reporter cells remained in the glomerular capillaries, while others repopulated the mesangial area and, in part, extended their cytoplasmic processes toward the surrounding capillaries. When the cells were transferred into glomeruli subjected to transient mesangiolysis induced by monoclonal antibody 1-22-3, in situ expression of 13-galactosidase was amplified 7-12-fold, and the enhanced level of expression continued for up to 8 wk. The mesangial cell vector system thus achieves site-specific delivery of an exogenous gene into the glomerulus and is amenable to in situ amplification and sustained expression by preconditioning of the target site. (J. Clin. Invest. 1994. 94:497-505.)
Introduction
Glomerular disease is one of the major causes of chronic renal failure. During the past 5 yr, various molecules have been implicated as mediators of glomerular injury (1) (2) (3) . However, the majority of studies have been based on in vitro observations or on techniques used to detect gene expression or gene products in the affected tissue, without assessing the direct effect of such molecules on the generation or repair of injury in vivo. An important challenge in this field will be to elucidate which mediators are pivotal in different types of glomerular damage using appropriate in vivo systems.
To identify the molecules involved in glomerular injury and repair, direct injection of bioactive substances or conventional gene transfer vectors, i.e., viral vectors or liposomes, into the circulation could be a possible approach (4, 5) . However, this route would affect not only the glomerulus but other sites within the kidney, particularly the vasculature, as well as other organs. Use of transgenic animals has the limitation that there is a need for cell type-specific regulatory elements which allow the transgene to be expressed in the glomerulus. Currently, therefore, there are no systems appropriate for the purpose of modulating glomerular function site specifically for a sustained period. In this report, we describe an approach which achieves site-specific delivery and sustained expression of a foreign gene in the glomerulus using an ex vivo gene transfer system.
Gene transfer has been effected into various organs including bone marrow, skin, brain, muscle, lung, liver, artery, heart, kidney, and joint (5) (6) (7) (8) (9) . In these cases, exogenous genes have been applied to the target organ or tissue by direct injection or local instillation of materials. In the kidney, however, the glomeruli are small structures (100-200 ,um in diameter) scattered throughout the renal cortex (3 X 104_-1 X 106 glomeruli/ kidney) (10) and, therefore, cannot be gained access by these conventional approaches. Access via the renal circulation would be a reasonable approach, but in this case the entire renal vasculature may be affected. To restrict the site of gene introduction to the glomerulus, we used the glomerular mesangial cell as a vector for gene delivery. In the rat glomerulus, the diameter of the capillaries ranges from 5 to 25 Mm (11) . Since the diameter of cultured rat mesangial cells ranges between 15 and 25 Mum, cells injected into the renal circulation are entrapped within the glomerular capillaries. Using genetically engineered mesangial cells, we introduced the bacterial ,-galactosidase gene (LacZ)' into the glomerulus in vivo. By inducing a selective local stimulus to transient mesangial proliferation before the introduction of these cells, we successfully amplified the product of the exogenous gene and achieved its sustained expression within the glomerulus.
Methods
General experimental strategy. The gene which encodes for bacterial /3-galactosidase (LacZ) was introduced into rat mesangial cells in vitro, 1 . Abbreviations used in this paper: AXG%, percentage of glomerular area stained by X-gal; BAG, ,3-gal-at-gag; DMSA, di-mercapto-succinic acid; LacZ, bacterial fl-galactosidase gene; LTR, long terminal repeat; neo, neomycin phosphotransferase gene; Up/Ucr ratio, ratio of urinary protein concentration to urinary creatinine concentration; X-gal (XG), and the cells were transferred into the rat kidney via renal artery injection. After 4 h, 1, 2, 4, 8, and 14 wk, both kidneys were removed and processed for glomerular isolation and tissue sections, and the expression of the gene product was examined histochemically. To amplify the introduced gene and its product in situ, the glomerulus was "preconditioned" using a monoclonal antibody 1-22-3 which causes mesangiolysis followed by transient 
mg/ml).
A high /3-galactosidase-expressing clone, RM4/BG715, was selected from the neomycin-resistant mesangial cells using the X-gal (5-bromo-4-chloro-3-indolyl ,3-D-galactopyranoside) assay to evaluate expression levels (8) . Resistant clones were fixed in 0.5% glutaraldehyde, 2 mM MgCl2, and 1.25 mM EGTA in PBS for 10 min at room temperature. After washing repeatedly, cells were incubated at 37°C for 2 h in X-gal solution containing 1 mg/ml X-gal (Sigma Immunochemicals), 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 3H20, 2 mM MgCl2, 0.01% sodium desoxycholate, and 0.02% NP-40 in PBS (pH 7.4). The clone that exhibited the most intense blue color, RM4/BG715, was used as the reporter cell. The cells were expanded and stored in liquid nitrogen until use. A /3-galactosidase-negative clone, RM4-4, was also established from the original culture pool of mesangial cells by a limiting dilutional method.
To confirm the mesangial cell phenotype of the reporter cell, the appropriate morphological features, and staining for desmin, a-smooth muscle actin and Thy 1-associated antigen were sought. Antibodies used were: rabbit antidesmin antiserum (Sigma Immunochemicals; 1:20 dilution), mouse anti-mesangial cell monoclonal antibody 1-22-3 (16) (1:20 dilution), mouse anti-a-smooth muscle actin monoclonal antibody (Sigma Immunochemicals; 1:200 dilution), goat anti-rabbit immunoglobulins FITC (Sigma Immunochemicals; 1:32 dilution), and goat anti-mouse immunoglobulins FITC (Sigma Immunochemicals; 1:50 dilution).
To confirm the successful introduction of the exogenous genes into the reporter cell, the expression of neo as well as LacZ was examined by Northern hybridization. Confluent cultures of RM4/BG715 and the original mesangial cells, RM4, were harvested, and total RNA was extracted by a single-step method (17) . Northern hybridization was performed as described previously (18) . The mM MgCl2 in PBS, incubated overnight, embedded in compound, and sectioned (6-/Am slice) by a cryostat onto gelatine-coated slides. Before the X-gal assay was commenced, the tissue sections were postfixed at 40C for 10 min. Glomeruli were isolated as described above, fixed in 2% paraformaldehyde/0.2% glutaraldehyde buffer at 40C overnight, and then subjected to the X-gal assay.
The X-gal assay on frozen sections and isolated glomeruli was performed as follows: fixed materials were washed by cold PBS containing 2 mM MgCl2 repeatedly, transferred into detergent solution (2 mM MgCl2, 0.01% sodium desoxycholate, and 0.02% NP-40 in PBS) for 10 min on ice, and then incubated in 1 mg/ml of X-gal solution (as .. 31, product was expressed quantitatively using an X-gal (XG) score on isolated glomeruli. In each X-gal-positive glomerulus, the percentage of glomerular area stained by X-gal (AXG%) was graded into four levels: -5%, 5 -25%, 25 -50%, 50 -100%, and the mean value per positive glomerulus was calculated: mean AXG (%) = (2.5 X a) + (15 x b) + (37.5 X c) + (75 x d)/a + b + c + d, where a, b, c, and d are the number of X-gal-positive glomeruli showing grades of -5%, 5 -25%, 25 -50%, and 50 -100%, respectively. The X-gal score per kidney was calculated using the following formula:
XG score = mean AXG (%) x total positive glomeruli (%).
During the course of experiments, each X-gal score was compared with the mean value obtained at 4 h and expressed as a fold increase.
Histochemical analysis of reporter cell location in the glomerulus. To identify the location of the reporter cells within the glomerulus, we performed histochemical analyses of the injected kidney. To prepare X-gal-paraffin sections, injected kidneys were fixed by 2% paraformaldehyde/0.2% glutaraldehyde buffer at 40C overnight. The cortex was cut into small pieces and reacted in X-gal solution for 3 h at 370C with agitation. The longer incubation was used to allow X-gal solution to permeate into the tissues. The tissues were fixed again with 10% formaldehyde at room temperature overnight, washed with PBS, and embedded in paraffin. The sections prepared (3 Mm) were counterstained with PAS and examined using a light microscope.
Resin sections were also prepared using X-gal-treated tissues. After allowing the X-gal reaction to proceed for 3 h, the tissues were washed with PBS and postfixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) at 40C overnight. Samples were then incubated in 1% osmium tetroxide/1.5% potassium cyanoferrate in 0.1 M sodium cacodylate buffer at room temperature for 1 h, washed three times with 0.1 M sodium cacodylate buffer, dehydrated in ethanol, and embedded in Spurr's embedding medium (TAAB Laboratories, Berkshire, United Kingdom). Spurr's medium was chosen so that tissue can be processed from 100% ethanol without the need for propylene oxide which causes dissolution of the X-gal precipitates from tissues (22) . Sections (0.5 pm) stained with toluidine blue were used for light microscopic analyses.
Effect of cell transfer on the structure and function of the kidney.
For histopathological analysis, paraffin sections (5 Mm) of the kidneys fixed in 10% formaldehyde were counterstained with PAS and hematoxylin.
To estimate the effect of cell transfer on the single kidney function,
we used "mTc di-mercapto-succinic acid (DMSA). Since circulating ssmTc DMSA is excreted by glomerular filtration and taken up by the tubular cells, its uptake is proportional to renal function (23) . Reporter cells (0.8-1.0 x 106 cells) were introduced into the left kidneys of six rats via the renal artery. As a sham injection, 700 ML of DME was used in two rats. After 1 wk, 99mTc DMSA (50 kBq/rat) was injected into the tail vein of anesthetized rats. 2 h later, both kidneys were removed, and the radioactivity in each was counted separately. The effect of cell transfer on proteinuria was evaluated as follows. The ratio of urinary protein concentration to urinary creatinine concentration (Up/Ucr ratio) was used to express the degree of proteinuria since this value is relatively independent of changes in urine volume (24) . To determine the normal range of Up/Ucr ratio in adult rats, urine samples were obtained from 22 normal male adult Sprague-Dawley rats. Urine creatinine concentration was measured by autoanalyzer (Beckman Instruments, Inc., Fullerton, CA), and urinary protein concentration was assessed using the Bradford assay (25) .
Evaluation of humoral and cellular immune response to reporter cells. To estimate the possible humoral immune response to the transferred cells, reporter cells fixed with cold methanol were reacted with undiluted normal rat serum or test sera and then incubated with FITCconjugated rabbit anti-rat immunoglobulins (1:100 dilution; Southern Biotechnology Associates, Birmingham, AL). To evaluate the cellular immune response, infiltration of T lymphocytes and monocytes/macrophages into the glomeruli was examined using frozen sections of the injected kidneys after 2 and 4 wk. Fixed sections were reacted with a monoclonal antibody against rat T lymphocytes (MRC OX-52; Serotec Ltd., Oxford, United Kingdom) ( 1:100 dilution) or rat monocytes/macrophages (EDI; Serotec Ltd) (1:500 dilution) and then incubated with goat anti-mouse immunoglobulins FITC (1:50 dilution; Sigma Immunochemicals). Immunofluorescence was examined under a fluorescence microscope.
Statistical analysis. Statistical analysis was performed using the Mann-Whitney test (nonparametric method) to compare data in different groups of animals. P value of < 0.05 was used to indicate a statistically significant difference.
Results
Characterization of the reporter mesangial cell clone, RM4/BG715 Using replication-defective BAG virus, we established a neomycin-resistant reporter clone, RM4/BG715. Northern analysis detected the transcripts of the introduced genes, 4.0-kb LacZ and 3.6-kb neo, in RM4/BG715 but not in the uninfected mesangial cells RM4 (Fig. 1 A) . X-gal analysis revealed a high level of /3-galactosidase activity in this reporter clone (Fig. 1   B) but not in the uninfected cells (Fig. 1 C) . RM4/BG715 showed the "hill and valley" formation ( Fig. 1 B) and positive staining for desmin, a-smooth muscle actin, and Thy 1 -associated antigen (not shown) seen in cultured rat mesangial cells. No evidence of transformation was observed in the reporter cell as assessed by its growth activity in soft agar (26) , and no replication-competent virus was detected in the conditioned medium of this clone. The mesangial cell phenotypes and the high level of 63-galactosidase expression of RM4/BG715 were observed to be constant through 7-17 passages.
Distribution and kinetics of reporter cells after transfer into the normal kidney Confluent reporter cells were trypsinized, suspended in DME, and injected into the left kidney via the renal artery. 4 h after injection, 17-62% (34+8%; mean+SE, n = 6) of isolated glomeruli were positive for X-gal staining (Fig. 2 A) . Reporter cells were not detected in the glomeruli from the contralateral kidneys (Fig. 2 B) . X-gal analysis of the frozen sections revealed that the reporter cells had accumulated in the glomerulus in a site-specific manner (Fig. 2 C) . No X-gal-positive cells were detected in afferent or efferent arteriole or in interstitial capillaries. Likewise, the contralateral kidneys (Fig. 2 D) and lungs (not shown) were also negative. Injection of medium alone or of a P-galactosidase-negative clone, RM4-4, did not induce any X-gal-positive areas in the injected kidney (data not shown), indicating that the observed enzymatic activity was derived exclusively from the introduced LacZ gene.
The kinetics of the P-galactosidase expression during the course of experiments was studied. During the initial 4 wk, the mean percentages of X-gal-positive glomeruli were sustained above 30%; the percentage increased to 57+13% (mean±SE, n = 5) at 1 wk, and then gradually declined to 35+14% (n -4) at 2 wk and 30+16% (n = 4) at 4 wk, respectively (Fig.  3) . Maximum efficiency, 83%, was achieved in a kidney at 1 wk after injection. After 8 and 14 wk, ,3-galactosidase expression was only detected in the occasional glomerulus (-6%).
,e3-Galactosidase activity was never detected in the glomeruli of the contralateral kidneys.
Using X-gal paraffin sections, we detected reporter cells within the glomerular capillaries even 1 wk after cell transfer (Fig. 4 A) . Some cells extended along the endothelium (Fig. 4 B) or occupied the capillary lumens (Fig. 4 C) . However, other cells seemed to migrate within the glomerulus and make connections with each other (Fig. 4 D) . Microscopic analysis of Xgal-treated resin sections revealed that these cells, indeed, populated the mesangial area (Fig. 4 , E and F) and, at least in part, extended their cytoplasmic processes toward the surrounding capillaries not unlike the resident mesangial cells (Fig. 4 E) .
Kinetics of reporter cells after transfer into kidneys undergoing transient mesangial regeneration
Cells were transferred into regenerating glomeruli 3 d after the administration of monoclonal antibody 1-22-3. 4 h after cell injection, 21-67% (50±11%; mean±SE, n = 4) of glomeruli were positive for X-gal staining, with the distribution of the cells being as sparse as in the normal glomeruli (Fig. 5 A) .
Within 7 d, however, the,/-galactosidase activity was amplified in situ, and the X-gal-positive areas were dramatically expanded (Fig. 5 B) . The regenerative state of the glomerulus improved the efficiency of gene introduction as well as the expression level of the gene product; the percentage of X-galpositive glomeruli per injected kidney increased from 34±8% in normal to 50±11% in regenerating kidneys at 4 h, and from 57±13% to 75±4% at 1 wk. Again, the reporter cells were neither detected in other portions of the injected kidneys (Fig.  5 C) nor in the contralateral kidneys, except for one injected kidney where a small number of reporter cells was detected in the medullary interstitium. Transfer of the /3-galactosidasenegative clone RM44 did not produce any X-gal positivity in the injected kidneys (Fig. 5 D) , indicating that the enhanced enzyme expression was derived from the exogenous transgene.
In each glomerulus, expansion of the reporter cells progressed during the first 2 wk and then reached a plateau (shown in Mean AXG (%) in Table I ). P-Galactosidase activity per kidney indicated by X-gal score was also markedly increased during the first 2 wk, and the high level of expression (7-12-fold increase compared with the 4-h score) continued for at least 8 wk (Fig. 6) . In contrast to this result from isolated glomeruli, frozen sections of injected kidneys at 4 and 8 wk revealed evidence of glomerulosclerosis where X-gal positivity had diminished.
To confirm that the increased expression of the exogenous gene was due to the replication of the transferred cells, we examined the kinetics of replication-defective reporter cells which were treated with mitomycin C. A suspension of the mitomycin-treated cells was injected into the regenerating kidneys 3 d after 1-22-3 treatment. After 7 d, in contrast to the replication-competent cells (Fig. 7 A) , expansion of X-galpositive area of the glomerulus did not occur in the mitomycintreated cells (Fig. 7 B) ; the percentage of X-gal-positive area in each glomerulus was 2.8±0.1% (mean±SE) in the group of treated cells (n = 4) vs 27.5+5.2% in the untreated group (n = 5). The X-gal score was 61±21 (mean±SE) in mitomycintreated cells vs 2,014±288 in untreated cells. These findings indicated that the increased expression of /3-galactosidase was due to replication of the reporter cells.
Effect of reporter cell transfer on the structure and function of the kidney Histological change. The majority of the glomeruli where reporter cells were transferred showed normal appearance at 4 h and 1 wk, except for the presence of entrapped cells within the capillaries. At 1 wk after cell transfer, the reporter cells typically occupied capillary lumens (Fig. 8 A) . Nodular remodeling of peripheral capillaries (Fig. 8 B) or expansion of the glomerular tuft (Fig. 8 C) was occasionally detected at this stage. After 4 and 8 wk, however, increased cellularity and matrix expansion in glomeruli were observed in the two kidneys which exhibited the most prominent X-gal staining (not shown). In four other kidneys examined, the glomerular alteration was modest, showing occasional nodular/segmental sclerosis or increased cellularity. At this stage, infiltration of mononuclear cells into the interstitium was detected even when histological change in the glomerulus was minor. The 1-22-3-treated glomeruli containing reporter cells, however, exhibited histological evidence of pronounced hypercellularity, matrix expansion, and glomerular hypertrophy at 1 wk in association with expansion of the reporter cell population (Fig. 8 D) . In contrast to the selflimiting course of 1-22-3-induced injury itself, the glomerular damage was progressive, and global or segmental sclerosis was observed in the glomeruli at 4 and 8 wk (not shown). This progressive injury was not detected after the transfer of replication-defective cells which were pretreated with mitomycin C.
Single kidney function. Using 99mTc DMSA uptake, the effect of reporter cell transfer on the function of injected kidneys was evaluated. 1 wk after cell transfer, the function of the injected kidneys was 19.7±2.6% (mean±SE, n = 6) lower than that of the noninjected side. Injection of medium alone did not induce any functional change, suggesting that the observed alteration was caused by the entrapped reporter cells.
Proteinuria. In the normal adult rats, the Up/Ucr ratio ranged from 0.02 to 0.52 (0.23±0.03, mean±SE of 22 rats). When the cells were transferred into the normal kidneys, the Up/Ucr ratios were 0.32±0.06 at 4 h, 0.11±0.08 at 1 wk, 0.17±0.01 at 2 wk, and 0.22±0.12 at 4 wk, respectively. These values were not statistically different from normal. We next examined the effect of cell transfer on proteinuria in the 1-22-3-treated kidneys. The anti-mesangial cell antibody induced transient proteinuria with peak on days 5-10 after the antibody injection. When the reporter cells were transferred into these kidneys, an enhanced and prolonged proteinuric response (not statistically different) was monocytes/macrophages in the glomeruli and the interstitium was observed 2 and 4 wk after cell transfer (data not shown).
Discussion
Using the cultured mesangial cell as a vector for gene delivery, we have devised a novel gene transfer system which targets a microscopic structure in the kidney, the glomerulus. This system has several advantages over conventional in vivo gene transfer methods which use viral vectors or liposomes, i.e., high effi- The reporter cells were transferred into the kidneys 3 d after the 1-22-3 treatment. After 4 h, 1, 2, 4, and 8 wk, both kidneys were sampled, and percentages of X-gal-positive glomerulus were calculated using isolated glomeruli from injected kidneys (L, left) or contralateral kidneys (R, right).
In each X-gal-positive glomerulus, AXG% was graded into four levels: -5%, 5 During the study, we constantly observed site-specific accumulation of the reporter cells in the glomeruli after injection into the renal artery. Reporter cells were not detected in other portions of the injected kidneys, in the contralateral kidneys, or in other organs. In contrast to other conventional gene transfer approaches, this is a distinct advantage of the mesangial cell vector system. Using this method, the glomerulus can be targeted and functionally modified in a site-specific manner. However, we cannot exclude the possibility that a small population of the cells could have been "ectopically" trapped and were not identified on routine histological sectioning. Further investigation will be required to clarify this point.
The system we describe is not without limitations. Transfer of vector cells reduced renal function to a limited extent and induced structural changes in the glomerulus. To overcome these problems, further modification of this method will be required. For example, in this study, we used mesangial cells after prolonged culture, whereas it may be better to use early passage cells which maintain their differentiated characteristics. To obviate the risk of rejection and to allow for long-term gene expression, use of inbred strains or autologous cell transfer will also be essential. We have successfully used genetically engineered mesangial cells derived from a biopsy of the contralateral kidney for this latter purpose (our unpublished observations).
Utilization of the monoclonal antibody 1-22-3, which induced not only the amplified gene expression but also injury of the glomerulus, should also be modified. The use of replicationdefective reporter cells revealed that the progressive damage was mainly due to uncontrolled proliferation of the vector cells. Preliminary data indicate that lower doses of 1-22-3 or cell transfer before or 1 wk after 1-22-3 treatment induces modest proliferation of vector cells and less damage of the glomerulus (our unpublished observation). Alternatively, genetic engineering of vector cells to control the growth activity could also achieve appropriate and self-limiting replication of the cells. Using these modifications, it would be possible to exert tight control over the vector cell replication in vivo allowing for expansion of the cells without causing progressive glomerular injury.
In this system, the efficiency of gene introduction varied from 17 to 67% at 4 h after cell injection. Several factors could affect the efficiency of this system, e.g., body weight of the recipients, cell size, injected cell number, unusual branching of the renal artery, reactive constriction of renal vasculature, or the pressure of cell injection. As far as examined, we did not detect an obvious correlation between efficiency (percentage of X-gal-positive glomeruli) and animal size, cell number, or the pressure of injection (our unpublished data). Since unusual branching of renal artery affects the distribution of vector cells within the kidney, cell injection was performed into the renal artery in its most proximal part. Reactive constriction of renal vasculature, especially of the afferent arterioles, is a possible reason for the difference in efficiency from animal to animal. If so, combination with a vasodilator might improve the efficiency of gene transfer. We also observed that the gene transfer efficiency was improved in the regenerating glomerulus. This may be caused by increased entrapment and/or survival of the cells due to alterations in: (a) diameter and length of glomerular capillaries; (b) expression of adhesion molecules; or (c) supply of growth and/or survival factors in the glomerulus.
By preconditioning of the target site with the monoclonal antibody 1-22-3, we observed amplified and prolonged expression of,-galactosidase in the glomerulus. Although macrophages infiltrating into the 1-22-3-treated glomeruli may have endogenous ,f-galactosidase activity, we concluded that the amplified enzymatic activity was derived exclusively from the introduced LacZ gene because: (a) no /3-galactosidase activity was detected in the noninjection side of kidneys where infiltrating macrophages are present; (b) injection of /3-galactosidasenegative cells did not induce any X-gal-positive areas in the injected kidneys; and (c) marked amplification of /3-galactosidase activity was observed after the transfer of replication-competent reporter cells but not of replication-defective cells. These findings clearly showed that the 3-galactosidase activity in the glomerular macrophages is far less than that in the established reporter cell, and that the X-gal assay we used discriminated the exogenous /3-galactosidase from the endogenous enzyme. In this study, the high levels of /3-galactosidase expression were detected for up to 8 wk, but frozen sections of injected kidneys at 4 and 8 wk exhibited evidence of glomerulosclerosis where X-gal positivity had diminished. This discrepancy may have been due to the difficulty of isolating sclerotic glomeruli using the conventional sieving approach.
In the established reporter cells, the LacZ gene was transcribed under the control of Moloney murine leukemia virus promoter, long terminal repeat (LTR). Some reports have suggested that the viral LTR is not effective for long-term in vivo gene expression (28) . Our data showed that this promoter provided sustained expression of genes in the glomerulus for up to 4 wk with a decline thereafter. This limited expression may be due to rejection of the introduced cells since we detected histological evidence of cellular infiltration in the injected kidneys. Some investigators, however, have reported that the viral LTR becomes inactive in vivo in the absence of an immune response or host cell death (28, 29) . Utility of the viral promoter for the purpose of long-term gene expression by this system should be evaluated further, by comparing reporter cells which express a foreign gene under the control of different regulatory elements.
In summary, we have demonstrated site-directed gene transfer into the glomerulus via a mesangial cell vector. Since mesangial cells, but not other glomerular cells, are well-characterized and can be easily cultured even from biopsy samples, they would be suitable as vectors for introducing genes into the glomerulus via autologous transplantation. This system will allow for the assessment of the pathophysiological function of specific molecules within the glomerulus and also will allow therapeutically relevant molecules to be targeted to this microscopic structure. Indeed, targeting of some genes to the glomerulus has been reported recently by Isaka (27) who used the hemagglutinating virus of Japan-liposome method to demonstrate the pathogenic roles of transforming growth factor-f and platelet-derived growth factor in inducing glomerular injury. Sustained and/or amplified expression of site-directed exogenous genes using the mesangial cell vector system should be a powerful tool in evaluating the contribution of specific molecules to the evolution of chronic glomerular injury.
